• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. AFX; BIFURCATED STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. AFX; BIFURCATED STENT Back to Search Results
Model Number BA28-120/I16-40
Device Problems Failure To Adhere Or Bond (1031); Leak/Splash (1354); Torn Material (3024)
Patient Problems Failure of Implant (1924); Thrombus (2101)
Event Date 05/10/2017
Event Type  Injury  
Manufacturer Narrative
The devices involved in the event will not be returned for evaluation, they remain implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Devices remain implanted in the patient.
 
Event Description
The patient initially implanted with a bifurcated stent and a suprarenal aortic extension.A routine follow up showed a possible tear in the graft material and thrombus inside the stent.On (b)(6)2017 an angiogram was completed and the physician was unable to identify the presence of an endoleak.On (b)(6)2017 the physician elected to implant an ovation limb extension in the left iliac limb to resolve the issue.It was reported the patient was discharged from the hospital.There have been no additional adverse events reported for this patient.
 
Manufacturer Narrative
The manufacturing lot evaluation confirmed all devices met specifications prior to release.The devices remain implanted in the patient and were not returned, no evaluation completed.At the completion of the clinical assessment, the type 3b endoleak was refuted.Instead, this endoleak was determined to be a type 1b.Additionally, there was evidence to support the reported intragraft thrombus and the secondary procedure with implantation of an iliac extension (ovation).Although, the limb was reported to be positioned with the distal end into the vessel wall in a tortuous native anatomy, the most likely cause of the loss of seal could not be determined due to lack of relevant medical information.The final patient disposition was reported to be discharged from the hospital.Endologix continues to investigate this event and similar events to ensure the highest quality and patient safety.These types of events will be monitored and trended as part of the quality system.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
BIFURCATED STENT
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
Manufacturer Contact
michelle caulfield
2 musick
irvine, CA 92618
9495984671
MDR Report Key6632737
MDR Text Key77274192
Report Number2031527-2017-00300
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00818009014184
UDI-Public(01)00818009014184(17)180602
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/10/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/02/2018
Device Model NumberBA28-120/I16-40
Device Lot Number1341510-011
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received05/10/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/08/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age88 YR
-
-